Skip to content
The Nexus
DossierENTITY

$29 million

Coverage of $29 million in the Nexus archive.

Earliest in view: Aug 11 · 11:17 UTCMost recent: Aug 11 · 11:17 UTC
Co-mentioned in this coverage
Harvard Bioscience Inc.organization1HBIOorganization1HOLLISTON, Mass.place1Automated Insightsorganization1Zacks Investment Researchorganization1medical instruments makertopic1
Recent coverage
  • BUSINESSAug 11 · 11:17 UTCWTOP DC
    Harvard Bioscience: Q2 Earnings Snapshot

    Harvard Bioscience Inc. reported a $2.9 million loss in its second quarter, while posting revenue of $22.7 million for the period. Losses, adjusted for non-recurring costs and amortization costs, totaled 14 cents per share. For the current quarter ending in September, the company expects revenue between $21 million to $22.6 million.

$29 million · Dossier · The Nexus